FDA Inspection 1226786 — Chris Engebose
The FDA completed an inspection of Chris Engebose on December 28, 2023 in Luxemburg, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 28, 2023
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Luxemburg, WI (United States)